Page 1 | Search Results | Blood | American Society of Hematology

Skip to Main Content

Skip Nav Destination

1-3 of 3

Sort by

Sort Order Select

Journal Articles

Do PROs Tell the Whole Story? Differential Outcomes Based on Patient-Reported Outcomes (PROs) Versus Performance-Based Metrics (PBM) on Cognition for Patients Receiving Chimeric Antigen Receptor (CAR)-T Cell Therapy

Irena Tan, Rachel Cusatis, Emma Crawford, Aline Thiengmany, Claire Piehowski, Idayat Akinola, Juliana Craig, Sheila Lahijani, Matthew J. Frank, Nirav N. Shah, Anita D'Souza, David B. Miklos, Lori Muffly, Kathryn E Flynn, Surbhi Sidana

Blood (2021) 138 (Supplement 1): 3043.

https://doi.org/10.1182/blood-2021-145746

Published: 2021

Journal Articles

Worsening Financial Toxicity Among Patients Receiving Chimeric Antigen Receptor t-Cell (CAR-T) Therapy: A Mixed Methods Longitudinal Study

Rachel Cusatis, Irena Tan, Claire Piehowski, Idayat Akinola, Emma Crawford, Juliana Craig, Aline Thiengmany, Matthew J. Frank, David B. Miklos, Nirav N. Shah, Anita D'Souza, Jennifer M Knight, Lori Muffly, Kathryn E Flynn, Surbhi Sidana

Blood (2021) 138 (Supplement 1): 567.

https://doi.org/10.1182/blood-2021-146032

Published: 2021

Journal Articles

Heterogeneous Definitions of Secondary Acute Myeloid Leukemia (AML) Yield Distinct Outcomes in Response to First-Line Treatment with Hypomethylating Agents (HMA) and Venetoclax (Ven)

Irena Tan, Matthew Schwede, Paul Phan, Raymond Yin, Tian Y Zhang, Gabriel N. Mannis

Blood (2021) 138 (Supplement 1): 1216.

https://doi.org/10.1182/blood-2021-147886

Published: 2021